Capital International Investors
SAGE

Capital International Investors’s Sage Therapeutics SAGE Stock Holding History

Capital International Investors’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-69,010
Closed -$5.97M – 463
2020
Q4 		$5.97M Hold
69,010
– – ﹤0.01% 423
2020
Q3 		$4.22M Sell
69,010
-366,301
-84% -$18.6M ﹤0.01% 415
2020
Q2 		$18.1M Sell
435,311
-3,241,036
-88% -$118M 0.01% 358
2020
Q1 		$106M Sell
3,676,347
-137,729
-4% -$7.98M 0.04% 210
2019
Q4 		$275M Buy
3,814,076
+157,060
+4% +$19.3M 0.09% 165
2019
Q3 		$513M Buy
3,657,016
+516,724
+16% +$86.4M 0.2% 120
2019
Q2 		$575M Buy
+3,140,292
New +$536M 0.23% 109

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return